Human Metabolic Health- Diabetes, Obesity & Endocrinology

Welcome Message

We are delighted to invite participants from around the world to join us for the 32nd International Conference on Human Metabolic Health – Diabetes, Obesity & Endocrinology, which will be held on April 27–28, 2026, in Dubai, UAE.

Guided by the theme “ Shaping the Future of Metabolic Health through Science and Innovation ” this conference will bring together leading experts, researchers, clinicians, and academicians to explore the latest breakthroughs in diabetes management, obesity research, and endocrine science. The event aims to foster collaboration and innovation, addressing the global challenges of metabolic disorders through multidisciplinary perspectives and transformative ideas.

From molecular mechanisms to clinical practices and public health strategies, the conference will highlight advancements that are redefining the way we understand and manage human metabolism. Delegates will gain valuable insights from distinguished speakers and contribute to interactive discussions designed to inspire new approaches in both research and healthcare delivery.

We warmly welcome you to share your findings, exchange ideas, and connect with fellow professionals committed to improving global metabolic health. Together, let us shape a healthier, more sustainable future through the power of science and collaboration.

We look forward to meeting you in Dubai, UAE, for an inspiring and impactful gathering in April 2026.

Target Audience

• Endocrinologists
• Diabetologists
• Obesity Specialists
• Metabolic Disease Researchers     
• Clinical Nutritionists & Dietitians
• Physicians & General Practitioners       
• Pediatric Endocrinologists     
• Cardiologists & Hypertension Specialists
• Gastroenterologists & Hepatologists
• Clinical Pharmacologists & Toxicologists
• Nurses specializing in Diabetes, Obesity, and Endocrinology         
• Public Health Professionals         
• Epidemiologists         
• Health Policy Makers         
• Healthcare Administrators      
• Biomedical Scientists & Translational Researchers         
• Academic Professors & Educators in Endocrinology, Metabolism, and Nutrition         
• Graduate Students         
• PhD Scholars in Metabolic Health and Endocrinology         
• Post-Doctoral Fellows in Diabetes, Obesity, and Hormonal Research         
• Researchers in Hormonal Regulation, Insulin Resistance, and Metabolic Disorders         
• Obesity & Lifestyle Intervention Specialists         
• Exercise Physiologists & Physical Activity Researchers         
• Digital Health Innovators & Telemedicine Experts in Metabolic Health

About Conference

We are excited to invite participants from around the world to the 32nd International Conference on Human Metabolic Health – Diabetes, Obesity & Endocrinology, taking place on April 27–28, 2026, in Dubai, UAE. This premier gathering will focus on shaping the future of metabolic health through science and innovation, bringing together leading researchers, clinicians, endocrinologists, diabetologists, obesity specialists, public health experts, and industry professionals for an engaging program of keynote lectures, scientific sessions, poster presentations, panel discussions, and interactive workshops.

The conference provides a dynamic platform to explore the latest advancements in diabetes management, obesity prevention, hormonal regulation, lifestyle interventions, translational endocrinology, and emerging technologies in metabolic health. Participants will have the opportunity to exchange knowledge, engage in collaborative discussions, and gain insights into strategies that are transforming the understanding and treatment of metabolic disorders worldwide.

Endocrinologists, dialectologists, obesity specialists, physicians, nurses, dietitians, researchers, academicians, public health professionals, students, and industry leaders are encouraged to participate, present their research, and contribute to shaping innovative solutions in the field. Presenters will receive certificates of participation, and outstanding contributions will be recognized with special awards.

Join us in Dubai, UAE, in April 2026 for an inspiring, engaging, and impactful conference where science, collaboration, and innovation converge to advance global metabolic health.

Conference Highlights

The 32nd International Conference on Human Metabolic Health – Diabetes, Obesity & Endocrinology in Dubai, UAE, April 27–28, 2026 will feature a thoughtfully curated program designed to advance knowledge, innovation, and collaboration in metabolic health. Attendees will benefit from:

• Expert-Led Interactive Sessions: Gain practical insights through workshops and hands-on demonstrations led by world-renowned endocrinologists, diabetologists, and obesity specialists.
• Innovative Research Presentations: Learn about cutting-edge findings in diabetes management, obesity prevention, endocrine disorders, hormonal therapies, and lifestyle interventions.
• Distinguished Speaker Forums: Engage with thought-leaders sharing global perspectives on clinical practice, translational research, and public health strategies.
• Focused Discussion Panels: Explore current challenges, emerging trends, and multidisciplinary approaches to metabolic health.
• Exhibitions and Technology Showcases: Discover breakthrough diagnostic tools, therapeutic devices, digital health solutions, and nutrition innovations.
• Recognition of Excellence: Outstanding research and contributions will be celebrated through awards, poster presentations, and acknowledgment of early-career scientists.

Why to attend

Metabolic Health – Diabetes, Obesity & Endocrinology in Dubai, UAE, April 27–28, 2026. This event brings together the world’s leading clinicians, researchers, healthcare professionals, and innovators to explore the latest breakthroughs in diabetes, obesity, and endocrine care. Experience first hand how science and innovation are transforming the understanding, prevention, and treatment of metabolic disorders.

The conference offers a unique opportunity to engage with pioneering research, cutting-edge therapies, and emerging technologies. Interactive sessions, expert-led discussions, and hands-on workshops will equip attendees with actionable insights to enhance clinical practice, improve patient outcomes, and drive public health initiatives. The multidisciplinary nature of the event ensures that every participant can gain perspectives that span research, clinical application, policy, and industry innovation.

Beyond knowledge, the conference is a hub for meaningful collaboration. Delegates will connect with peers from across the globe, build strategic partnerships, and explore opportunities for joint research, mentorship, and professional growth. Recognition of innovative work through awards, poster presentations, and special sessions ensures that excellence is celebrated and shared.

By attending, you will not only expand your expertise but also play an active role in shaping the future of metabolic health. Join us in Dubai to collaborate, innovate, and be part of a transformative experience that advances global strategies for managing diabetes, obesity, and endocrine disorders.

Sessions and Tracks

Track 1: Obesity and Metabolic Syndrome: Mechanisms and Management

Obesity is a multifaceted metabolic disorder influenced by genetics, diet, and environment. It significantly increases the risk of insulin resistance, cardiovascular disease, and fatty liver. Exploring the molecular pathways of adipogenesis and energy regulation is critical. Research focuses on gut microbiota, neurohormonal signaling, and mitochondrial function. Effective interventions require an integration of behavioral, pharmacologic, and surgical strategies. Understanding the biological roots of obesity may help reverse the global epidemic.

Research Themes:

• Molecular Pathways of Adipose Tissue Regulation
• Gut Microbiome and Energy Homeostasis
• Novel Therapeutic Strategies for Obesity

Track 2: Precision Medicine in Diabetes Management

Advancements in genomic profiling and personalized therapy are reshaping how diabetes is treated. Precision medicine enables clinicians to tailor treatment based on genetic, metabolic, and lifestyle factors. This approach helps identify early biomarkers for type 1 and type 2 diabetes risk. Integration of AI and big data analytics allows for more accurate disease prediction. Genetic counselling and population-specific studies are paving new pathways in therapeutic planning. The ultimate goal is to achieve individualized glycaemic control with minimal side effects.

Key Focus Areas:

• Genomic Insights and Diabetes Risk Prediction
• Personalized Pharmacotherapy in Diabetes
• Artificial Intelligence in Clinical Decision Making

Track 3: Endocrine Regulation and Hormonal Imbalance

The endocrine system governs metabolism through a network of hormones and feedback loops. Disruptions in these systems lead to disorders like hypothyroidism, Cushing’s syndrome, and PCOS. Investigating hormone-receptor interactions offers insights into metabolic regulation. Advances in diagnostics now allow for precise hormone profiling and functional assays. Environmental endocrine disruptors are emerging as major contributors to hormonal imbalance. Bridging endocrinology with molecular biology enhances targeted intervention strategies.

Core Discussion Points:

• Hormone Signaling Pathways in Metabolic Disorders
• Environmental Endocrine Disruptors
• Diagnostic Innovations in Hormonal Analysis

Track 4: Insulin Resistance and Cellular Metabolism

Insulin resistance remains a central feature of metabolic syndrome and type 2 diabetes. It arises from defects in insulin receptor signaling, inflammation, and lipid metabolism. Cellular studies reveal mitochondrial dysfunction as a key driver of metabolic impairment. Research now focuses on reversing resistance through nutritional modulation and pharmacological agents. The interplay between muscle, liver, and adipose tissue metabolism is under deep investigation. Understanding these networks offers potential for curative strategies.

Scientific Highlights:

• Mitochondrial Dysfunction in Insulin Resistance
• Lipid-Induced Metabolic Stress
• Nutritional Modulation of Insulin Sensitivity

Track 5: Pediatric Endocrinology and Early Metabolic Disorders

Early-life nutrition and endocrine function play a vital role in long-term metabolic health. Increasing childhood obesity and juvenile diabetes demand urgent attention. Hormonal imbalances during growth affect both physical and cognitive development. Genetic predispositions combined with lifestyle patterns amplify early disease risk. Preventive care through dietary regulation and physical activity is critical. Pediatric endocrinology is becoming central to sustainable health strategies for future generations.

Emerging Frontiers:

• Childhood Obesity and Insulin Dynamics
• Growth Hormone Deficiencies and Developmental Health
• Genetic Markers of Pediatric Endocrine Disorders

Track 6:  Nutrition, Lifestyle, and Metabolic Optimization

Diet and lifestyle remain the foundation of metabolic health. Precision nutrition integrates individual metabolic profiling to craft effective dietary interventions. Research explores plant-based diets, intermittent fasting, and microbiome interactions. Lifestyle modification programs incorporating stress management and exercise have proven metabolic benefits. Public health initiatives now emphasize sustainable and culturally adaptable interventions. Integrating digital tools enhances adherence and long-term outcomes.

Strategic Areas of Study:

• Precision Nutrition and Personalized Dietetics
• Physical Activity and Metabolic Reprogramming
• Digital Health Tools for Lifestyle Management

Track 7: Diabetic Complications and Preventive Care

Chronic hyperglycemia affects multiple organ systems over time. Diabetic neuropathy, nephropathy, and retinopathy remain leading causes of disability. Prevention depends on tight glycemic control, early diagnosis, and multidisciplinary management. Advances in biomarkers now enable earlier detection of complications. Regenerative medicine and nanotechnology offer new therapeutic prospects. A patient-centered approach can reduce the global burden of diabetic complications.

Innovation Streams:

• Novel Biomarkers for Diabetic Complications
• Regenerative Therapies in Tissue Repair
• Clinical Guidelines for Early Intervention

Track 8: Neuroendocrinology and Metabolic Integration

The brain acts as a key regulator of appetite, glucose homeostasis, and hormonal signaling. Disruptions in neuroendocrine communication contribute to obesity and metabolic disorders. Recent imaging and molecular studies highlight the role of hypothalamic circuits. Hormones such as leptin and ghrelin are central to energy regulation and food behavior. Understanding brain-metabolism interaction opens doors for novel neurotherapeutics. Integration of neuroscience and endocrinology redefines metabolic medicine.

Investigative Domains:

• Hypothalamic Regulation of Energy Balance
• Neurohormonal Pathways in Appetite Control
• Cognitive and Behavioral Aspects of Metabolism

Track 9: Reproductive Endocrinology and Metabolic Links

Metabolic dysfunction profoundly impacts reproductive health in both sexes. Disorders like PCOS and hypogonadism are tightly linked to insulin resistance. Emerging research explores how adipokines and reproductive hormones interact. Obesity-induced inflammation disrupts fertility and menstrual cycles. Managing metabolic balance restores reproductive function and hormonal harmony. This track focuses on the intersection between fertility, metabolism, and endocrine therapy.

Research Pathways:

• Polycystic Ovary Syndrome and Insulin Dynamics
• Male Hypogonadism and Metabolic Dysfunction
• Adipokines in Reproductive Health

Track 10: Gut Microbiome and Endocrine Interactions

The gut microbiota acts as a metabolic and endocrine organ. It produces bioactive molecules that influence insulin sensitivity and inflammation. Dysbiosis contributes to obesity, diabetes, and autoimmune endocrine disorders. Microbiome-targeted probiotics and prebiotics are showing therapeutic promise. Understanding host-microbe cross-talk may lead to precision microbiome therapies. Integrating microbiome research into endocrinology enhances holistic metabolic care.

Exploratory Dimensions:

• Microbial Metabolites and Hormone Regulation
• Probiotic Therapies for Diabetes and Obesity
• Gut-Brain-Endocrine Communication Pathways

Track 11: Inflammation and Immune Crosstalk in Metabolic Disorders

Metabolic diseases are increasingly recognized as inflammatory in nature. Chronic low-grade inflammation alters insulin signaling and lipid metabolism. Immune cells within adipose tissue play crucial roles in metabolic regulation. Targeting inflammatory pathways has shown promise in improving glucose control. Understanding immunometabolic interactions bridges endocrinology and immunology. This perspective creates a foundation for novel anti-. inflammatory therapeutics

Key Research Directions:

• Cytokine Networks in Insulin Resistance
• Adipose Tissue Immunology
• Anti-inflammatory Interventions in Metabolic Disease

Track 12: Cardiometabolic Health and Vascular Endocrinology

The connection between endocrine function and cardiovascular health is vital. Hormones such as insulin, thyroid hormones, and cortisol influence vascular tone and lipid metabolism. Endothelial dysfunction plays a major role in diabetic heart disease. Studies now explore hormonal modulation to prevent atherosclerosis and hypertension. Integrating endocrinology with cardiology strengthens preventive strategies. The goal is to maintain both metabolic balance and vascular integrity.

Clinical Insights:

• Hormonal Influences on Vascular Function
• Diabetic Cardiomyopathy Mechanisms
• Integrated Endocrine-Cardiac Therapeutics

Track 13: Thyroid and Adrenal Function in Metabolic Regulation

Thyroid and adrenal hormones have profound effects on energy metabolism. Alterations in their secretion can trigger obesity, insulin resistance, and fatigue. Advances in molecular endocrinology now clarify these glandular interactions. Stress hormones such as cortisol influence appetite and glucose metabolism. Early identification of thyroid-adrenal imbalance is critical for metabolic recovery. Precision diagnostics and targeted hormone therapies are leading modern treatment approaches.

Key Discussion Elements:

• Thyroid Dysfunction and Energy Expenditure
• Cortisol and Stress-Induced Metabolic Disorders
• Diagnostic Biomarkers for Glandular Health

Track 14: Pharmacological Advances in Endocrine and Metabolic Therapy

Drug development for metabolic diseases is rapidly evolving. Novel molecules target glucose transporters, incretin hormones, and lipid pathways. Advances in delivery systems improve patient compliance and minimize side effects. Personalized pharmacogenomics is reshaping diabetes and obesity treatment. Integration of AI-driven models supports optimized drug discovery. This track highlights cutting-edge research in therapeutic innovation.

Therapeutic Developments:

• Incretin-Based and SGLT2-Targeted Therapies
• Pharmacogenomic Insights in Metabolic Medicine
• Nanocarrier Systems for Hormone Delivery

Track 15: Genetic and Epigenetic Control of Metabolism

Genetics and epigenetics shape individual susceptibility to metabolic disorders. DNA methylation, histone modification, and RNA signaling regulate energy metabolism. Environmental and nutritional exposures during early life have lifelong effects. Understanding these molecular signatures aids in predicting disease risk. Epigenetic therapy is emerging as a frontier in diabetes prevention. Integrating omics data enhances precision diagnostics.

Research Insights:

• Epigenetic Modifiers in Obesity and Diabetes
• Nutrigenomics and Gene-Environment Interaction
• Noncoding RNAs in Metabolic Regulation

Track 16: Clinical Endocrinology and Diagnostic Technologies

Rapid innovations are transforming endocrine diagnostics. Continuous glucose monitors, hormone sensors, and digital assays improve clinical accuracy. Artificial intelligence enhances diagnostic interpretation and pattern recognition. Early detection of endocrine abnormalities allows better preventive care. The future lies in portable, real-time monitoring technologies. Clinicians now rely on smart diagnostics to refine treatment strategies.

Diagnostic Innovations:

• Biosensor Technology in Metabolic Testing
• AI-Driven Diagnostic Systems
• Remote Monitoring for Endocrine Disorders

Track 17: Endocrine Disrupting Chemicals and Environmental Health

Environmental toxins interfere with hormone signaling and metabolism. Exposure to plastics, pesticides, and heavy metals impacts endocrine balance. These chemicals alter thyroid, reproductive, and insulin pathways. Research focuses on identifying biomarkers of exposure and developing safer alternatives. Public health policies are essential for reducing long-term risk. Raising awareness supports preventive environmental endocrinology.

Ecological Aspects:

• Mechanisms of Endocrine Disruption
• Environmental Exposure Biomarkers
• Public Health Strategies for Risk Mitigation

Track 18: Geriatric Metabolism and Age-Related Endocrine Changes

Aging brings progressive alterations in hormonal and metabolic function. Decreased insulin sensitivity, sarcopenia, and thyroid shifts are common features. Understanding these changes aids in managing age-related diseases. Nutrition, exercise, and hormonal therapy can optimize elderly metabolic health. Emerging studies focus on longevity hormones like DHEA and IGF-1. Geriatric endocrinology is vital for promoting healthy aging.

Key Discussion Lines:

• Hormonal Adaptations During Aging
• Metabolic Syndrome in the Elderly
• Longevity-Linked Endocrine Factors

Track 19: Digital Health and Artificial Intelligence in Endocrinology

Digital tools are transforming diabetes and metabolic care. AI algorithms assist in predicting glycemic trends and personalizing treatment. Wearable sensors and mobile apps support lifestyle adherence and remote monitoring. Data-driven decision-making improves patient engagement and outcomes. Integration of telemedicine strengthens accessibility to endocrine care. The digital era marks a new chapter in precision endocrinology.

Technological Focus:

• AI-Powered Predictive Analytics
• Wearable Devices and Glucose Monitoring
• Virtual Endocrine Clinics and Telehealth

Track 20: Translational and Integrative Metabolic Research

Bridging basic science with clinical application is vital for real-world progress. Translational research converts molecular insights into practical therapies. Integrative approaches link endocrinology, nutrition, genetics, and behavioral science. Cross-disciplinary collaborations foster innovation in prevention and treatment. Emphasis is placed on population-based outcomes and sustainability. This track unites laboratory discovery with patient-centered care.

Integration Platforms:

• Bench-to-Bedside Metabolic Research
• Multidisciplinary Collaboration Models
• Sustainable Health Innovation Frameworks

Market Analysis

Metabolic disorders, including diabetes, obesity, and endocrine conditions, are rising at an unprecedented rate. Over 537 million adults are currently living with diabetes globally, with numbers expected to reach 643 million by 2030. Obesity continues to surge worldwide, contributing to chronic diseases and increased healthcare burdens, while endocrine disorders such as thyroid and adrenal dysfunctions add further complexity.

This growing prevalence drives strong demand for innovative therapies, preventive strategies, and advanced diagnostic tools. The market for metabolic health solutions spans pharmaceuticals, medical devices, digital health, and lifestyle interventions, presenting significant opportunities for collaboration and research.

The 32nd International Conference on Human Metabolic Health – Diabetes, Obesity & Endocrinology offers a timely platform to connect healthcare professionals, researchers, and industry leaders. Participants will explore emerging trends, share insights, and build partnerships to address the pressing challenges in metabolic health worldwide.

Projected Trends and Future Impact: 

Global estimates suggest a steady upward trend in diabetes cases through 2035. If unaddressed, this growth will strain healthcare resources and increase mortality rates. Strategic interventions and healthier living practices are vital to reversing the curve.

Rising Obesity Trends Across the Globe: 

Across continents, obesity prevalence continues to climb, driven by lifestyle and environmental factors. Shifts in diet, reduced physical activity, and socioeconomic changes are key contributors to this global trend. Understanding regional patterns can help health organizations design tailored interventions to reduce obesity and its related diseases.

Abstract Submission & Registration

Invited speakers, researchers and practitioners from across the globe are encouraged to submit original works including abstracts, full?papers, case?studies, poster presentations or e?posters by selecting a topic from the “Call for Abstract” or their area of research interest.

Abstract Guidelines:

• Abstracts must be submitted in English and should not exceed 500 words.
• The title should be formatted in sentence case and clearly reflect the research focus.
• Please list the full name of the presenting author and any co-authors, include their institutional affiliation(s).
• Include a short biography of the presenting author (maximum 150 words) and provide a recent professional photograph.

Review Process:

All submissions will be evaluated by the Scientific Committee, and authors will receive notification of acceptance or request for revisions via email, typically within 24 – 48 hours after submission.

Publication:

Accepted abstracts will be included in the conference proceedings and published in the partner journal or symposium series.

Abstract Submission URL: https://mental-health.neurologyconference.com/abstract-submission.php

Registration:
Once your abstract is accepted, please proceed to register via the nominal Registration portal to confirm your participation. Secure your registration soon to reserve your place in this major international gathering on metabolic health.

Visa Guidelines

The organizing committee of the 18th International Conference on Addiction & Psychiatry 2026 would like to clarify that we are not directly involved in visa processing. However, we can assist participants by providing essential supporting documents such as:

• Letter of Invitation
• Letter of Abstract Acceptance
• Registration Payment Receipt

Please note that you may be required to submit additional documents to the embassy along with these supporting materials.

Letter of Invitation: The official Letter of Invitation serves as proof that your paper submission and registration application have been accepted by the conference committee. The letter will be issued in English and can help facilitate your visa application process.

Past conference

The 31st International Conference on Human Metabolic Health – Diabetes, Obesity & Endocrinology, held on April 10–11, 2025 in Dubai, UAE, concluded with remarkable success, establishing itself as one of the most impactful global gatherings in the field. The conference brought together leading endocrinologists, diabetologists, metabolic health experts, researchers, clinicians, nutrition scientists, and policymakers from more than 35 countries, creating an exceptional platform for scientific exchange and interdisciplinary collaboration.

The event featured:

• 180+ international participants

• 35 keynote and plenary lectures by distinguished global speakers

• 20+ scientific and technical sessions

• Interactive workshops on advanced therapies, digital health tools, lifestyle medicine, and metabolic research innovations

• Poster presentations showcasing emerging research in diabetes, obesity, and endocrinology

Participants praised the conference for its high-quality scientific content, strong global representation, and the rich networking opportunities it offered. Breakthrough research on diabetes management, cutting-edge obesity interventions, endocrine disorders, metabolic syndrome, and the integration of AI and digital technologies in metabolic care was presented, encouraging new collaborations and future research partnerships.

The conference succeeded in fostering a vibrant community of experts dedicated to advancing global metabolic health. The positive feedback and strong engagement demonstrated the growing importance of international cooperation in addressing diabetes, obesity, and endocrine disorders worldwide.

Building on this success, we are delighted to host the 32nd International Conference on Human Metabolic Health – Diabetes, Obesity & Endocrinology, scheduled for April 27–28, 2026 in Dubai, UAE, continuing our mission to drive innovation, research excellence, and global health impact.